Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema AMARIN

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiAmarin Corporation plc: Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event52DUBLIN, Ireland and BRIDGEWATER, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its support for a petition filed with the U.S. Food and Drug Administration...
► Artikel lesen
22.04.AMARIN CORP PLC - 8-K, Current Report1
22.04.Amarin Corporation plc: Amarin Announces Results of Annual General Meeting of Shareholders102DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024...
► Artikel lesen
08.04.Amarin Corporation plc: Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.246
06.04.Amarin Corporation plc: New REDUCE-IT Analyses Show VASCEPA/VAZKEPA (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups574-- Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp(a), LDL-C Levels -- -- Lp(a) Results Published Simultaneously in the Journal of the American...
► Artikel lesen
04.04.Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe8
03.04.Why Amarin Stock Was Rocketing Higher on Wednesday9
03.04.Amarin: IP Protection For VAZKEPA In Europe Now Extended Into 20395
03.04.Amarin Corporation plc: Amarin Provides Update on VAZKEPA (Icosapent Ethyl) Intellectual Property Portfolio in Europe104DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company received a Decision to Grant from the European Patent...
► Artikel lesen
03.04.AMARIN CORP PLC - 8-K, Current Report3
29.03.Teva, following Hikma complaint, alleges Amarin 'locked up' Vascepa ingredient to block generics33
25.03.Amarin Corporation plc: Research Evaluating Benefits of VASCEPA/VAZKEPA (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo128-- Subgroup Analyses from REDUCE-IT® and Mechanistic Data on Icosapent Ethyl(IPE)/Eicosapentaenoic Acid (EPA) Featured at the Meeting -- DUBLIN, Ireland and BRIDGEWATER, N.J., March 25, 2024 (GLOBE...
► Artikel lesen
06.03.Sirivadhanabhakdi Family Tenders for Entire Business of 'Amarin Corporations'1
01.03.Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates31
29.02.Why Is Amarin Stock Trading Lower After Q4 Earnings?29
29.02.Amarin Corporation PLC reports results for the quarter ended in December - Earnings Summary11
29.02.Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61M25
29.02.AMARIN CORP PLC - 8-K, Current Report1
29.02.AMARIN CORP PLC - 10-K, Annual Report5
29.02.Amarin Corporation plc: Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update277-- Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 ---- Reaffirms Year-End 2023 Cash Position of $321 Million and Full-Year Positive Cash...
► Artikel lesen
Seite:  Weiter >>